NCT04079621View on ClinicalTrials.gov

Short Course Radical Cure of P. Vivax Malaria in Nepal

PHASE4CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

October 27, 2021

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2024

Conditions
MalariaMalaria, VivaxMalaria,Falciparum
Interventions
DRUG

primaquine

Primaquine regimen over 7 days (0.5mg/kg/day for 7 days)

Trial Locations (2)

Unknown

Malakheti Hospital, Malakheti

Tikapur Hospital, Ṭikāpur

All Listed Sponsors
collaborator

Tribhuvan University, Nepal

OTHER

lead

Menzies School of Health Research

OTHER

NCT04079621 - Short Course Radical Cure of P. Vivax Malaria in Nepal | Biotech Hunter | Biotech Hunter